SCHEMBL15740209

SCHEMBL15740209

C=Cc1cc(C2[C@@H]3OC(C)(C)O[C@@H]3[C@@H](CO[Si](C)(C)C(C)(C)C)N2C(=O)OC(C)(C)C)c(=O)[nH]c1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17178699 0.90 — —
SCHEMBL15740208 0.89 — —
SCHEMBL15740122 0.89 — —
SCHEMBL17175110 0.88 — —
SCHEMBL15740156 0.87 — —
SCHEMBL15740123 0.86 MEN1 (0.31) —
SCHEMBL15740121 0.84 — —
SCHEMBL15718942 0.78 PNP (0.38) —
SCHEMBL15718943 0.78 PNP (0.38) —
SCHEMBL15740306 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3251674-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BioCryst Pharmaceuticals, Inc. (US) 2017-12-06 — — EP disclosed
US-20150291596-A1 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BIOCRYST PHARMACEUTICALS, INC. 2015-10-15 — — US disclosed
WO-2014078778-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BIOCRYST PHARMACEUTICALS, INC. (US) 2014-05-22 — — WO disclosed
Send feedback